DHFR and colorectal carcinoma: In CRC, first-line chemotherapy includes nucleoside synthetase inhibitors such as 5-Fu and capecitabine, ribonucleotide reductase inhibitors hydroxyurea and gemcitabine, as well as the dihydrofolate reductase inhibitor methotrexate (Fig. 3B).